AI Is Changing Cancer Research and Drug Development

AI-powered healthcare technologies are helping researchers improve cancer studies by supporting smarter treatment planning, better patient selection, and more informed clinical trial decisions. By analyzing large volumes of medical and biological data, these tools are making drug development faster, more efficient, and increasingly data-driven.

Read more: https://bostongene.com/news-an....d-publications/news/

Understanding Human Biology Through AI and Multiomics Research

BostonGene and Unilever are working together to study how AI and integrated data approaches can reveal patterns in human biology. This collaboration reflects a broader shift toward using advanced analytics in scientific exploration.

Explore how data driven research is shaping new ways of understanding biology here: https://bostongene.com/news-an....d-publications/news/

AI-Driven Disease Modeling Takes Focus at JSMO 2026

At JSMO 2026 in Yokohama, BostonGene shared how its disease modeling platform is helping advance precision oncology. By integrating diverse data sources, the approach supports better prediction of treatment outcomes, improved clinical trial design, and more informed therapeutic decisions. The model is increasingly being used by biopharma partners to strengthen research and patient care.

Read more on how AI is transforming oncology and drug development.

BostonGene and ImmunoGenesis Partner to Advance Precision Immunotherapy

BostonGene and ImmunoGenesis have announced a strategic collaboration to accelerate the development of IMGS-001, a next-generation immunotherapy targeting PD-L1 and PD-L2. By leveraging AI-driven multiomics and spatial biology, the partnership aims to better understand tumor biology, improve patient selection, and overcome resistance to existing immunotherapies.

Read more: https://bostongene.com/news-an....d-publications/news/

BostonGene Showcases Breakthrough AI Innovations in Cancer Research at AACR 2026

BostonGene will present 13 abstracts at the American Association for Cancer Research Annual Meeting 2026, showcasing its advanced AI platform for drug discovery and precision oncology. The research focuses on improving patient stratification, identifying new biomarkers, and enhancing clinical trial outcomes through integrated multiomic data and AI-powered insights.

Read the full news to discover how BostonGene is shaping the future of AI in cancer research: https://bostongene.com/news-an....d-publications/news/